Patents by Inventor Benoit Smagghe

Benoit Smagghe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Media for stem cell proliferation and induction
    Patent number: 11976295
    Abstract: The present application discloses a cell culture media for growth, maintenance and induction of reversion to a less mature state of a cell comprising a MUC1* activating ligand.
    Type: Grant
    Filed: January 12, 2023
    Date of Patent: May 7, 2024
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • Humanized anti-MUC1* antibodies
    Patent number: 11897967
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Grant
    Filed: August 4, 2022
    Date of Patent: February 13, 2024
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • MEDIA FOR STEM CELL PROLIFERATION AND INDUCTION
    Publication number: 20230287338
    Abstract: The present application discloses a cell culture media for growth, maintenance and induction of reversion to a less mature state of a cell comprising a MUC1* activating ligand.
    Type: Application
    Filed: January 12, 2023
    Publication date: September 14, 2023
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS
    Publication number: 20230279141
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: June 8, 2021
    Publication date: September 7, 2023
    Inventors: Cynthia BAMDAD, Benoit SMAGGHE
  • HUMANIZED ANTI-MUC1* ANTIBODIES
    Publication number: 20230279142
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Application
    Filed: August 4, 2022
    Publication date: September 7, 2023
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • Humanized anti-MUC1* antibodies
    Patent number: 11746159
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: September 5, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS
    Publication number: 20230242678
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: June 27, 2021
    Publication date: August 3, 2023
    Inventors: Cynthia BAMDAD, Benoit SMAGGHE
  • Method of treating an NME7 expressing cancer with a peptide
    Patent number: 11702483
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: July 18, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • HUMANIZED ANTI-MUC1* ANTIBODIES
    Publication number: 20230183373
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Application
    Filed: August 4, 2022
    Publication date: June 15, 2023
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • Media for stem cell proliferation and induction
    Patent number: 11591565
    Abstract: The present application discloses a cell culture media for growth, maintenance and induction of reversion to a less mature state of a cell comprising a MUC1* activating ligand.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: February 28, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • ANTI-CANCER PEPTIDE
    Publication number: 20220289865
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: April 12, 2022
    Publication date: September 15, 2022
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS
    Publication number: 20220259324
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: August 3, 2021
    Publication date: August 18, 2022
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • NME INHIBITORS AND METHODS OF USING NME INHIBITORS
    Publication number: 20220218846
    Abstract: The present application discloses inhibitors of NME family of proteins.
    Type: Application
    Filed: December 10, 2021
    Publication date: July 14, 2022
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia C. BAMDAD, Benoit SMAGGHE
  • ANTI-VARIABLE MUC1* ANTIBODIES AND USES THEREOF
    Publication number: 20220184120
    Abstract: The present application discloses an antibody, or fragment thereof, for the diagnosis, treatment or prevention of cancers wherein the antibody specifically binds to the PSMGFR peptide (SEQ ID NO:2) or a fragment thereof of the peptide.
    Type: Application
    Filed: July 12, 2021
    Publication date: June 16, 2022
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • NME INHIBITORS AND METHODS OF USING NME INHIBITORS
    Publication number: 20220089779
    Abstract: The present application discloses inhibitors of NME family of proteins.
    Type: Application
    Filed: May 3, 2021
    Publication date: March 24, 2022
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia BAMDAD, Benoit Smagghe
  • METHOD FOR DIAGNOSING AND TREATING CANCER USING NAÏVE STATE STEM CELL SPECIFIC GENES
    Publication number: 20210308213
    Abstract: The present application discloses a method for converting a cell to naïve state stem cells comprising contacting the cell to be converted with an NME protein.
    Type: Application
    Filed: June 21, 2021
    Publication date: October 7, 2021
    Inventors: Cynthia Bamdad, Benoit Smagghe, Mark G. Carter
  • NUCLEIC ACID ENCODING GENETICALLY ENGINEERED GROWTH FACTOR VARIANTS
    Publication number: 20200062812
    Abstract: The present application discloses a recombinantly made protein construct that preferentially forms multimers.
    Type: Application
    Filed: June 20, 2019
    Publication date: February 27, 2020
    Applicant: Minerva Biotechnologies Corporation
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • HUMANIZED ANTI-MUC1* ANTIBODIES AND USE OF CLEAVAGE ENZYME
    Publication number: 20190290692
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof and use of cleavage enzyme.
    Type: Application
    Filed: October 11, 2017
    Publication date: September 26, 2019
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe, Luke Deary
  • ANTI-NME ANTIBODY
    Publication number: 20190031778
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: August 24, 2018
    Publication date: January 31, 2019
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • ANTI-CANCER PEPTIDE
    Publication number: 20190031779
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: August 24, 2018
    Publication date: January 31, 2019
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe